IP, d. M., RS, d. S., IHR, d. P., BL, d. S. A. C., KP, d. S. B. T., JRB, d. S., & CA, P. (2026). Prebiotics attenuate depressive-like behavior, neuroinflammation and synaptic plasticity in Parkinson's disease by modulating butyrate-producing gut bacteria. Inflammopharmacology, 34(4), 2735. https://doi.org/10.1007/s10787-026-02152-2
Chicago Style (17th ed.) CitationIP, de Mendonça, da Silva RS, de Paiva IHR, da S A Costa BL, de Sousa Barbosa Teixeira KP, de Souza JRB, and Peixoto CA. "Prebiotics Attenuate Depressive-like Behavior, Neuroinflammation and Synaptic Plasticity in Parkinson's Disease by Modulating Butyrate-producing Gut Bacteria." Inflammopharmacology 34, no. 4 (2026): 2735. https://doi.org/10.1007/s10787-026-02152-2.
MLA (9th ed.) CitationIP, de Mendonça, et al. "Prebiotics Attenuate Depressive-like Behavior, Neuroinflammation and Synaptic Plasticity in Parkinson's Disease by Modulating Butyrate-producing Gut Bacteria." Inflammopharmacology, vol. 34, no. 4, 2026, p. 2735, https://doi.org/10.1007/s10787-026-02152-2.